Showing all 2 results
Nicorandil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Moisture-Shielded Tablet, packed exclusively in highly secure, heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile active ingredient.
Active Ingredient Strength Primary Clinical Function Nicorandil Ph.Eur./BP 5 mg Initiation / Titration Standard: Base therapeutic unit for the mandatory slow-titration protocol required to build patient tolerance and prevent severe “nitrate headaches.” Nicorandil Ph.Eur./BP 10 mg / 20 mg Global Cardiology Standard: High-dose adult maintenance therapy for severe, refractory stable angina pectoris. Excipients Maize Starch / Croscarmellose Sodium / Stearic Acid / Mannitol Low-Moisture Diluent / Superdisintegrant / Lubricant (Engineered specifically without hygroscopic binders to guarantee the tablet remains perfectly dry and structurally intact throughout its shelf life) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict chronic cardiology dispensing regimens).
Trimetazidine Tablets
FreeProduct Composition & Strength
We supply this product as an advanced Modified-Release (MR) Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the stability of both the active ingredient and the kinetic polymer matrix.
Active Ingredient Strength Primary Clinical Use Trimetazidine Dihydrochloride BP/Ph.Eur. 35 mg (Modified-Release) Global Standard: Twice-daily maintenance therapy for stable angina pectoris. Trimetazidine Dihydrochloride BP/Ph.Eur. 20 mg (Immediate-Release) Three-times-daily dosing for specialized dose titration or specific regional protocols. Excipients Hypromellose (HPMC) / Calcium Hydrogen Phosphate / Magnesium Stearate SR Polymer Matrix / Diluent / Lubricant (Engineered for strict 12-hour kinetic release)
